Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Fáberová V[au]:

Search results

Items: 35

1.

Nuclear Phosphoinositides-Versatile Regulators of Genome Functions.

Castano E, Yildirim S, Fáberová V, Krausová A, Uličná L, Paprčková D, Sztacho M, Hozák P.

Cells. 2019 Jun 28;8(7). pii: E649. doi: 10.3390/cells8070649. Review.

2.

Phospholipids and inositol phosphates linked to the epigenome.

Uličná L, Paprčková D, Fáberová V, Hozák P.

Histochem Cell Biol. 2018 Sep;150(3):245-253. doi: 10.1007/s00418-018-1690-9. Epub 2018 Jul 7. Review.

PMID:
29982846
3.

Nuclear phosphatidylinositol 4,5-bisphosphate islets contribute to efficient RNA polymerase II-dependent transcription.

Sobol M, Krausová A, Yildirim S, Kalasová I, Fáberová V, Vrkoslav V, Philimonenko V, Marášek P, Pastorek L, Čapek M, Lubovská Z, Uličná L, Tsuji T, Lísa M, Cvačka J, Fujimoto T, Hozak P.

J Cell Sci. 2018 Apr 13;131(8). pii: jcs211094. doi: 10.1242/jcs.211094.

4.

Tools for visualization of phosphoinositides in the cell nucleus.

Kalasova I, Fáberová V, Kalendová A, Yildirim S, Uličná L, Venit T, Hozák P.

Histochem Cell Biol. 2016 Apr;145(4):485-96. doi: 10.1007/s00418-016-1409-8. Epub 2016 Feb 4.

PMID:
26847181
5.
7.

Protective effect of simvastatin and VULM 1457 in ischaemic-reperfused myocardium of the diabetic-hypercholesterolemic rats.

Adameová A, Kuzelová M, Faberová V, Svec P.

Pharmazie. 2006 Sep;61(9):807-8.

PMID:
17020164
8.

Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury.

Adameová A, Kuzelová M, Andelová E, Faberová V, Pancza D, Svec P, Ziegelhöffer A, Ravingerová T.

Mol Cell Biochem. 2007 Jan;295(1-2):129-36. Epub 2006 Aug 10.

PMID:
16900395
9.

The ACAT inhibitor VULM1457 significantly reduced production and secretion of adrenomedullin (AM) and down-regulated AM receptors on human hepatoblastic cells.

Drímal J, Fáberová V, Schmidtová L, Bednáriková M, Drímal J Jr, Drímal D.

Gen Physiol Biophys. 2005 Dec;24(4):397-409.

10.

The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.

Adameová A, Kuzelová M, Faberová V, Svec P.

Pharmazie. 2005 Sep;60(9):714-5.

PMID:
16222877
11.

Iosimenol, a low-viscosity nonionic dimer: preclinical physicochemistry, pharmacology, and pharmacokinetics.

Sovak M, Terry R, Abramjuk C, Faberová V, Fiserova M, Laznicek M, Leuschner J, Malinak J, Zahradnik P, Masner O, Seligson A.

Invest Radiol. 2004 Mar;39(3):171-81.

PMID:
15076009
12.
13.

Urinary excretion of the 1,4-dihydropyridine calcium antagonist VULM 993 and its metabolites in the rat.

Stefek M, Faberova V, Musil S, Kakalik I.

Eur J Drug Metab Pharmacokinet. 2001 Oct-Dec;26(4):221-6.

PMID:
11808863
14.

Placental transfer of the antioxidant stobadine at different gestational stages in rabbits.

Ujházy E, Dubovický M, Faberová V, Zemánek M, Soltés L, Gajdosík A, Eybl V.

Methods Find Exp Clin Pharmacol. 2000 Nov;22(9):683-8.

PMID:
11294010
15.

Toxicological evaluation of the new calcium antagonist VULM 993.

Múcková M, Ujházy E, Sadlonová I, Faberová V, Dubovický M, Hózová R, Lazová J.

Gen Physiol Biophys. 1999 Oct;18 Spec No:105-11.

PMID:
10703728
16.

Placental transfer of stobadine in rabbits.

Ujházy E, Dubovický M, Soltés L, Faberová V, Zemánek M, Gajdosík A.

Life Sci. 1999;65(18-19):2011-4.

PMID:
10576457
17.

Pharmacokinetic study of stobadine.

Bezek S, Soltés L, Scasnár V, Bauerová K, Kállay Z, Durisová M, Mihalová D, Bohov P, Faberová V, Kukan M, Trnovec T, Koprda V.

Life Sci. 1999;65(18-19):2003-5.

PMID:
10576455
18.

Effect of propentofylline on [3H]-leucine incorporation into protein of postischemic rat brain.

Faberová V, Fabianová M, Noskovic P, Machová J.

Methods Find Exp Clin Pharmacol. 1996 Sep;18(7):449-52.

PMID:
8900217
19.

Effect of a combination of pentoxifylline and nimodipine on lipid peroxidation in postischemic rat brain.

Noskovic P, Faberová V, Fabianová M.

Mol Chem Neuropathol. 1995 Jun-Aug;25(2-3):97-102.

PMID:
8534330
20.

[Transplacental transfer of stobadine in rabbits in various stages of pregnancy--an approximation using a pharmacokinetic model].

Ujházy E, Faberová V, Dubovický M, Zemánek M, Jansák J, Dedík L, Durisová M.

Cesk Fysiol. 1995 Mar;44(1):15-7. Slovak.

PMID:
7758141
21.

Pharmacokinetics of heptacaine, a novel potent local anaesthetic agent, after rectal administration to rats.

Faberová V, Durisová M, Trnovec T, Divisová D.

Eur J Drug Metab Pharmacokinet. 1992 Jul-Sep;17(3):227-32.

PMID:
1490492
22.
23.

Pharmacokinetics of carbisocaine in rats and mice.

Bezek S, Faberová V, Scasnár V, Trnovec T, Durisová M, Kállay Z.

Eur J Drug Metab Pharmacokinet. 1988 Jan-Mar;13(1):27-34.

PMID:
3396611
24.

[Etimizol absorption from the small intestine in dogs: the dependence on dosage].

Trnovec T, Faberová V, Piotrovskiĭ LB, Durisová M, Gabauer I.

Biull Eksp Biol Med. 1986 Dec;102(12):729-30. Russian.

PMID:
3801627
25.

Disposition of ethimizol, a nootropic drug, in rats and mice.

Trnovec T, Durisová M, Bezek S, Burdáts P, Marko V, Faberová V, Zemánek M, Soltés L, Piotrovsky LB.

Drug Metab Dispos. 1986 Nov-Dec;14(6):718-23.

PMID:
2877833
26.

The disposition of the local anaesthetic, pentacaine, in rats and mice.

Bezek S, Scasnár V, Trnovec T, Durisová M, Faberová V, Benes L.

Biopharm Drug Dispos. 1986 Mar-Apr;7(2):137-50.

PMID:
3708121
27.

The pharmacokinetics of exaprolol and propranolol in rats with interrupted enterohepatic circulation.

Motheová O, Bezek S, Durisová M, Faberová V, Zemánek M, Misánikova K, Trnovec T.

Biopharm Drug Dispos. 1986 Mar-Apr;7(2):151-62.

PMID:
2871875
28.

Absorption of exaprolol from the in-situ gastrointestinal tract of rats and dogs.

Motheová O, Zemánek M, Faberova V, Trnovec T, Gabauer I, Styk J, Durisová M, Nosálová V.

J Pharm Pharmacol. 1985 Nov;37(11):816-9.

PMID:
2867165
29.

Tissue distribution of exaprolol in rat.

Faberová V, Trnovec T, Zemánek M, Bezek S, Durisová M, Tomcíková O.

Eur J Drug Metab Pharmacokinet. 1985 Jan-Mar;10(1):11-3.

PMID:
2863149
30.

Biliary excretion and enterohepatic circulation of two beta-adrenergic blocking drugs, exaprolol and propranolol, in rats.

Tomcíková O, Bezek S, Durisová M, Faberová V, Zemánek M, Trnovec T.

Biopharm Drug Dispos. 1984 Apr-Jun;5(2):153-62.

PMID:
6146357
31.

Disposition of exaprolol, a new beta-blocker, in rats.

Trnovec T, Zemánek M, Faberová V, Bezek S, Durisová M, Ujházy E, Tomcíková O.

Drug Metab Dispos. 1982 Sep-Oct;10(5):547-50.

PMID:
6128208
32.

[Effect of beta-adrenergic blocking agents on 14C-leucine incorporation into proteins in nervous tissue (author's transl)].

Machová J, Faberová V, Beno M.

Bratisl Lek Listy. 1981 Jul;76(1):11-20. Slovak. No abstract available.

PMID:
6114787
33.

The distribution in mice of intravenously administered labelled Candida albicans.

Trnovec T, Sikl D, Zemánek M, Faberová V, Bezek S, Gajdosík A, Koprda V.

Sabouraudia. 1978 Dec;16(4):299-306.

PMID:
377524
34.

The effect of fractions isolated from Candida albicans on phagocytic activity of the reticuloendothelial system in mice.

Trnovec T, Gajdosik A, Bezek S, Sikl D, Koprda V, Zemánek M, Faberová V.

J Reticuloendothel Soc. 1977 Aug;22(2):111-20. No abstract available.

PMID:
335065
35.

[Analysis of electroencephalogram during vigilance and petit mal by means of periodogram].

Faber J, Tosovský J, Dusek J, Taichmanová Z, Faberová V.

Cesk Neurol Neurochir. 1975 Dec;38(6):351-6. Czech. No abstract available.

PMID:
811362

Supplemental Content

Loading ...
Support Center